Laís Silva Santana , Guilherme José da Costa Borsatto , Marianna Leite , Maressa Mouty Rabello , Eberval Gadelha Figueiredo , João Paulo Mota Telles
{"title":"Susceptibility mapping of deep gray matter in Wilson’s disease: A systematic review and meta-analysis","authors":"Laís Silva Santana , Guilherme José da Costa Borsatto , Marianna Leite , Maressa Mouty Rabello , Eberval Gadelha Figueiredo , João Paulo Mota Telles","doi":"10.1016/j.parkreldis.2026.108235","DOIUrl":null,"url":null,"abstract":"<div><div>Quantitative susceptibility mapping (QSM) enables assessment of brain metal deposition. This meta-analysis evaluated QSM alterations in Wilson's disease (WD). PubMed, Embase, and Web of Science were searched up to September 2025 for studies reporting QSM measurements in neurological or hepatic WD and healthy controls (HCs). Twelve studies were included (325 WD, 254 HCs). Neurological WD showed higher susceptibility than HCs in the caudate (mean difference [MD] = 33.92, 95% CI: 18.14–49.70, p < .001), putamen (MD = 48.42, 95% CI: 29.66–67.17, p < .001), globus pallidus (MD = 62.24, 95% CI: 39.74–84.73, p < .001), thalamus (MD = 15.15, 95% CI: 10.15–20.15, p < .001), red nucleus (MD = 30.25, 95% CI: 12.57–47.93, p < .001), and dentate nucleus (MD = 16.65, 95% CI: 2.52–30.78, p = .02). Compared with hepatic-onset WD, neurological presentations showed higher susceptibility in the caudate nucleus (MD = 23.45, 95% CI: 1.17–45.73, p = .04), putamen (MD = 43.20, 95% CI: 2.62–83.78, p = .04), and thalamus (MD = 11.11, 95% CI: 7.53–14.69, p < .001). Hepatic-onset WD showed milder increases versus HCs in the globus pallidus (MD = 18.13, 95% CI: 4.42–31.85, p = .01), red nucleus (MD = 16.87, 95% CI: 12.11–21.63, p < .001) and dentate nucleus (MD = 11.61, 95% CI: 8.28–14.95, p < .001). QSM reveals marked susceptibility elevations in neurological WD and mild changes in hepatic WD.</div></div><div><h3>Trial registration</h3><div>CRD420251232999, <span><span>https://www.crd.york.ac.uk/PROSPERO/view/CRD420251232999</span><svg><path></path></svg></span>.</div></div>","PeriodicalId":19970,"journal":{"name":"Parkinsonism & related disorders","volume":"145 ","pages":"Article 108235"},"PeriodicalIF":3.4000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Parkinsonism & related disorders","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1353802026000611","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/12 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Quantitative susceptibility mapping (QSM) enables assessment of brain metal deposition. This meta-analysis evaluated QSM alterations in Wilson's disease (WD). PubMed, Embase, and Web of Science were searched up to September 2025 for studies reporting QSM measurements in neurological or hepatic WD and healthy controls (HCs). Twelve studies were included (325 WD, 254 HCs). Neurological WD showed higher susceptibility than HCs in the caudate (mean difference [MD] = 33.92, 95% CI: 18.14–49.70, p < .001), putamen (MD = 48.42, 95% CI: 29.66–67.17, p < .001), globus pallidus (MD = 62.24, 95% CI: 39.74–84.73, p < .001), thalamus (MD = 15.15, 95% CI: 10.15–20.15, p < .001), red nucleus (MD = 30.25, 95% CI: 12.57–47.93, p < .001), and dentate nucleus (MD = 16.65, 95% CI: 2.52–30.78, p = .02). Compared with hepatic-onset WD, neurological presentations showed higher susceptibility in the caudate nucleus (MD = 23.45, 95% CI: 1.17–45.73, p = .04), putamen (MD = 43.20, 95% CI: 2.62–83.78, p = .04), and thalamus (MD = 11.11, 95% CI: 7.53–14.69, p < .001). Hepatic-onset WD showed milder increases versus HCs in the globus pallidus (MD = 18.13, 95% CI: 4.42–31.85, p = .01), red nucleus (MD = 16.87, 95% CI: 12.11–21.63, p < .001) and dentate nucleus (MD = 11.61, 95% CI: 8.28–14.95, p < .001). QSM reveals marked susceptibility elevations in neurological WD and mild changes in hepatic WD.
期刊介绍:
Parkinsonism & Related Disorders publishes the results of basic and clinical research contributing to the understanding, diagnosis and treatment of all neurodegenerative syndromes in which Parkinsonism, Essential Tremor or related movement disorders may be a feature. Regular features will include: Review Articles, Point of View articles, Full-length Articles, Short Communications, Case Reports and Letter to the Editor.